🩺 Clinical Story — Medical Residency · Niterói, Brazil · ~1990

The Patient My Textbook Never Taught Me:
TB, HIV, and a Lesson in Clinical Thinking

A woman in her 70s. Pulmonary tuberculosis. No apparent risk factors. And then the HIV test came back positive. Dr. Alberto recalls the case from his medical residency that changed how he thinks about clinical history — and explains what the science says today.

By Dr. Alberto, MD  |  Infectious Disease Specialist  |  2026  |  Sources: CDC, WHO, Lancet, PubMed

▶ Watch the full video on YouTube

Infectious Diseases in Focus →

Some clinical lessons come from textbooks. Others come from a specific patient, on a specific afternoon, in a ward that smelled like disinfectant and felt like it was running out of beds. This is one of the second kind.

Niterói, 1990 — The Setting

It was my first or second year of medical residency, at a hospital in Niterói, in the state of Rio de Janeiro. The early 1990s were the height of the HIV and AIDS epidemic in Brazil, and our ward reflected that reality in a way that is hard to convey to anyone who wasn’t there. Beds were full. Cases were severe. The volume of patients suffering from HIV-related conditions was unlike anything most of us had seen or trained for.

I was on afternoon shift, reviewing patients, when a woman in her 70s arrived to be admitted, accompanied by her family. She had been diagnosed with pulmonary tuberculosis. I reviewed her X-ray — consistent with the diagnosis. I began ordering the routine workup.

The Professor’s Suggestion

Standing next to me was a professor from the infectious and parasitic diseases course. We were talking through the case when she said, matter-of-factly: “order an HIV test too. Anti-HIV.”

“Hey Vera — anti-HIV? For tuberculosis?”

“Go ahead and order it.”

My hesitation was genuine. She was an elderly widow. No apparent risk factors. Why would I test her for HIV? I added the test to the panel, not because I expected anything, but because the professor said to.

The Result

The anti-HIV test came back positive.

I was shaken. I went to talk to the family, to understand if there was any risk factor I had missed, any behavior that might explain the result. There wasn’t — at least not in the patient herself.

“No, she’s a widow. Her husband passed away some years ago.”

“What did he pass away from?”

“He had a problem — needed surgery. Received a blood transfusion.”

That was the answer. Her husband had received a blood transfusion at a time when blood products in Brazil were not yet routinely screened for HIV. He had been infected, and he had not known it. He passed the virus to his wife through sexual contact. He died. She lived — with the virus, silently, for years — until the immune suppression it causes created the conditions for tuberculosis to take hold.

⏱️ The HIV Incubation Period
HIV can take up to 10 years to progress from primary infection to symptomatic AIDS, depending on individual immune factors and access to treatment. This prolonged silent period is one of the reasons HIV remains underdiagnosed — particularly in populations that clinicians do not typically associate with risk.

The Bias I Had to Confront

Looking back, the assumption I made was not unusual for the time — or, frankly, for today. It was this: elderly people, particularly widows, are not sexually active, and therefore are not at risk for sexually transmitted infections. This assumption is wrong, it was wrong then, and it costs diagnoses.

The husband had passed away from the very disease he carried without knowing it, and he had transmitted it to his wife. Her risk factor was not her own behavior. It was her husband’s medical history — specifically, a blood transfusion that happened years before she showed any symptoms. That history would only be found by asking the right questions. And I almost didn’t ask.

⚠️ The Myth Broken
HIV infection in elderly individuals is real and underdiagnosed. It frequently goes undetected because clinicians — and patients themselves — do not consider it likely. A 2023 review found that older adults are diagnosed with HIV later in the course of disease, leading to worse outcomes. Assumptions about age and sexual activity are a clinical liability.

What the Science Says Today

The connection between tuberculosis and HIV that my professor recognized in 1990 — before it was standard teaching — is now among the most robustly documented relationships in infectious disease medicine.

5%US TB cases with confirmed HIV coinfection (CDC 2024)
16–21×More likely to develop active TB if HIV positive (WHO)
24%Mortality for HIV-TB coinfection vs. 11% for TB alone (Lancet 2024)
StandardHIV testing now recommended for ALL TB patients globally

HIV attacks and depletes CD4 T-lymphocytes — the immune cells most critical to controlling Mycobacterium tuberculosis. An HIV-positive individual is dramatically more susceptible to primary TB infection and to reactivation of latent TB. The two diseases amplify each other: TB accelerates HIV progression; HIV enables TB to flourish. Their intersection is one of the most deadly in global infectious disease.

📋 Current Clinical Guideline
HIV testing is now recommended for all patients diagnosed with active tuberculosis, regardless of age, apparent risk factors, or social history. This guideline exists precisely because the clinical picture can be misleading — and because identifying HIV coinfection fundamentally changes the treatment plan, including decisions about antiretroviral therapy timing and drug interactions.

The Lesson That Has Stayed With Me

Clinical history is not a formality. It is the most powerful diagnostic tool a physician has — and it only works when it is genuinely thorough and genuinely open-minded. The information that explained this patient’s HIV result was not hidden. It was there, in the family’s memory, waiting to be asked for.

Knowing the medical background of family members — not just the patient — is part of a complete clinical history. A husband’s blood transfusion in the 1980s, a parent’s unexplained illness, a sibling’s diagnosis never shared with the family — these details can unlock what no laboratory panel reveals on its own.

💡 Three Questions This Case Taught Me to Always Ask
1. What did family members die of? Not just “natural causes” — specifically.

2. Did the patient’s partner ever receive blood products, undergo surgery, or have a prolonged unexplained illness?

3. Am I assuming “low risk” based on the patient’s age, appearance, or social role — rather than on actual evidence?
A
Dr. Alberto
Physician and infectious disease specialist. Medical residency completed in Niterói, Rio de Janeiro, Brazil. Founder of No Infection Consulting & Education and the YouTube channel Infectious Diseases in Focus.

📚 References

  1. CDC. TB Among Persons with HIV: 2011–2024. TB in the US, 2024.
    https://www.cdc.gov/tb-surveillance-report-2024/data/persons-with-hiv.html
  2. WHO. Tuberculosis and HIV. Global Tuberculosis Programme.
    https://www.who.int/teams/global-tuberculosis-programme/tb-hiv
  3. Meintjes G, et al. Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality. The Lancet Infectious Diseases. 2024.
    https://pubmed.ncbi.nlm.nih.gov/40064284/
  4. CDC. TB Treatment for Persons with HIV. Global HIV-TB.
    https://www.cdc.gov/global-hiv-tb/php/globaltb/index.html
Medical Disclaimer: This article describes a personal clinical experience for educational purposes. It does not constitute medical advice. HIV testing guidelines and TB management should follow current national and international clinical guidance.